Clinical Trial Update: To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Botulax® versus Botox® for glabellar lines completed, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cosmetic Dermatology Conditions Involving Glabellar Lines

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Botulax (botulinum toxin type A)

Snippet

Sponsor: Hugel | Conditions: Skin Aging | Phase 3 | Status: COMPLETED